No definition available.
Acquired pure red cell aplasia [erythroblastopenia]
D3_ACQPUREREDCLLAPLASIA
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
158 |
4. Check minimum number of eventsNone |
158 |
5. Include endpointsNone |
158 |
6. Filter based on genotype QC (FinnGen only) |
158 |
Control definitions (FinnGen only)
- Control exclude
- D3_APLASTICANDOTHANAEMIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D60-D64
- Name in latin
- Erythroblastopenia [pura] acquisita
Similar endpoints
↥List of similar endpoints to
Acquired pure red cell aplasia [erythroblastopenia]
based on the number of shared cases.
Similar with more cases:
- Aplastic and other anaemias
- Anaemias
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1585 | 812 | 763 |
| Only index persons | 1228 | 642 | 586 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 50.27 | 49.87 | 50.40 |
| Only index persons | 51.23 | 50.58 | 51.94 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 158 | 78 | 80 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 61.35 | 56.48 | 66.11 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 146
- Matched controls
- 1458
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D60.9
ICD-10 Finland
Acquired pure red cell aplasia, unspecified
+∞
97.0
82
*
D64.9
ICD-10 Finland
Anaemia, unspecified
53.1
54.1
64
21
D60.0
ICD-10 Finland
Chronic acquired pure red cell aplasia
+∞
28.0
26
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.8
21.2
79
245
D60.1
ICD-10 Finland
Transient acquired pure red cell aplasia
+∞
20.3
19
*
122
Kela drug reimbursment
Aplastic anaemia
+∞
17.0
16
*
XW000
NOMESCO Finland
Bone marrow biopsy
14.1
15.3
26
22
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
10.9
14.5
28
31
D60.8
ICD-10 Finland
Other acquired pure red cell aplasias
+∞
13.8
13
*
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
+∞
12.7
12
*
WW500
NOMESCO Finland
Blood transfusion
13.4
12.3
21
18
UJF32
NOMESCO Finland
Coloscopy
3.8
11.4
58
214
UJF92
NOMESCO Finland
Capsular endoscopy
32.4
9.6
12
*
28404
ICD-8 Finland
Aplastic anaemia, Erythroblastopenia acquisita
+∞
8.4
8
*
L04AD01
ATC
ciclosporin; systemic
12.8
8.3
14
12
J01MA12
ATC
levofloxacin; systemic
3.3
7.6
42
159
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
7.5
63
315
D64.8
ICD-10 Finland
Other specified anaemias
31.7
7.2
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.1
6.9
27
77
A28
ICPC
Limited function/disability NOS
3.4
6.6
35
125
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
6.5
78
460
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
6.4
34
123
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
28.0
6.3
8
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
+∞
6.3
6
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
+∞
6.3
6
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
8.3
6.3
13
17
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
5.7
6.2
17
33
B82
ICPC
Anaemia other/unspecified
13.3
6.2
10
8
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.9
6.1
19
43
R50.9
ICD-10 Finland
Fever, unspecified
3.4
6.0
29
99
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
53
43
18.04
56.81
2.8
2.0
g/l
1.3
1.6
0.86
44
38
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
29
13.58
31.24
1.7
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
22
11
23.07
28.93
1.3
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
59
144
5.94
24.62
4.0
2.4
%
30.1
22.5
1.24
52
122
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
82
279
5.03
22.87
3.3
2.0
mg/l
3.2
2.9
0.41
73
231
(3023520) Reticulocytes [#/volume] in Blood
48
104
6.19
22.59
13.8
2.9
e9/l
63.8
63.7
0.01
41
81
(21494434) Karyotype in Bone marrow
17
10
18.93
20.58
1.2
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
99
478
3.87
15.47
5.3
2.5
ug/l
325.8
104.9
2.29
94
427
(42870588) Differential panel, method unspecified - Blood
86
386
3.69
14.87
13.2
5.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
18
10.46
14.59
1.9
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
24
8.34
12.98
1.7
3.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
100
532
3.40
12.52
14.4
5.6
%
0.7
0.6
0.92
95
487
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
20
8.79
12.10
1.3
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
101
548
3.34
12.09
14.4
5.5
%
2.7
2.7
0.15
96
503
(3019069) Monocytes/100 leukocytes in Blood
101
550
3.32
11.98
14.7
6.0
%
9.2
8.6
0.98
96
506
(3028026) IgM [Mass/volume] in Serum or Plasma
28
65
5.02
11.78
1.9
1.7
g/l
1.0
1.2
0.30
22
59
(3013115) Eosinophils [#/volume] in Blood
107
607
3.36
11.76
13.0
5.7
e9/l
0.2
0.2
0.04
97
532
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
15
18
9.10
11.69
1.3
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
104
582
3.30
11.66
12.5
5.5
e9/l
0.6
0.6
0.18
93
502
(3006315) Basophils [#/volume] in Blood
104
583
3.29
11.61
12.5
5.5
e9/l
0.0
0.0
0.14
93
506
(3003458) Phosphate [Moles/volume] in Serum or Plasma
45
152
3.74
11.59
11.0
6.3
mmol/l
1.1
1.1
0.12
40
137
(3002030) Lymphocytes/100 leukocytes in Blood
102
568
3.25
11.46
14.7
5.8
%
29.5
27.7
0.60
96
520
(40768797) Stomach Pathology biopsy report
46
161
3.62
11.20
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
11
11.72
11.19
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
32
6.61
11.14
1.3
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
30
78
4.51
10.99
2.3
2.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
20
8.18
10.75
1.3
1.8
u/ml
236.6
363.7
—
7
11
(3012095) Magnesium [Moles/volume] in Serum or Plasma
47
171
3.49
10.75
5.4
4.6
mmol/l
0.8
0.8
1.57
42
155
(3019309) Folate [Moles/volume] in Red Blood Cells
55
223
3.25
10.54
2.3
1.7
nmol/l
1101.8
1186.1
0.27
38
165
(3019198) Lymphocytes [#/volume] in Blood
103
596
3.09
10.47
13.2
5.7
e9/l
1.7
1.9
0.58
94
536
(3023368) Bacteria identified in Blood by Culture
71
336
3.02
10.39
7.9
3.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
20
39
5.73
10.13
2.1
2.6
mg/l
39.4
77.0
0.55
15
31
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
20
39
5.73
10.13
2.1
2.6
mg/l
36.4
35.2
0.03
15
31
(3018010) Neutrophils/100 leukocytes in Blood
97
557
2.92
9.75
13.6
5.6
%
55.9
57.5
0.56
92
514
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
17
8.24
9.42
1.4
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
73
370
2.81
9.17
6.1
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
5
25.77
9.05
1.4
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
94
545
2.79
9.05
11.3
3.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
30
90
3.88
9.02
12.1
7.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
46
183
3.14
8.94
1.7
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
35
119
3.49
8.76
8.7
6.0
mmol/l
-0.2
1.1
0.76
27
100
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
10
10.61
8.73
1.1
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
10
10.61
8.73
2.2
2.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
38
137
3.34
8.67
1.8
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
48
199
3.03
8.66
2.4
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
98
591
2.73
8.56
13.2
6.6
mmol/l
1.2
1.2
0.93
85
498
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
83
461
2.69
8.56
3.5
1.9
pmol/l
92.8
96.3
0.36
52
226
(3013650) Neutrophils [#/volume] in Blood by Automated count
108
694
2.76
8.15
18.9
8.3
e9/l
3.9
4.1
0.32
98
598
(3024561) Albumin [Mass/volume] in Serum or Plasma
85
487
2.61
8.10
9.4
4.5
g/l
33.7
35.7
2.47
77
449
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
14
8.37
8.09
4.7
4.6
u/ml
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
61
302
2.66
7.78
5.3
2.9
umol/l
360.3
8620.6
1.76
52
248
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
25
73
3.88
7.77
7.2
7.9
mmol/l
23.8
24.2
0.19
25
73
(3011412) CD3 cells [#/volume] in Blood
10
12
8.83
7.66
2.4
2.0
e9/l
0.6
1.0
—
5
5
(3018418) pH of Serum or Plasma
69
370
2.54
7.40
9.3
3.6
ph
7.4
7.4
0.56
15
73
(3007853) Bacteria identified in Skin by Aerobe culture
35
132
3.12
7.35
1.9
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
5
21.20
7.23
1.4
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
82
3.60
7.23
1.3
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
57
284
2.58
7.07
2.2
1.5
nmol/l
22.7
20.0
0.60
51
227
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
53
4.18
7.06
11.7
8.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
60
309
2.52
6.93
10.2
6.6
—
—
—
0
0
(3012544) pH of Venous blood
30
107
3.23
6.88
5.6
4.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
56
282
2.53
6.75
4.8
2.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
47
218
2.65
6.70
2.0
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
46
4.29
6.64
2.6
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
35
143
2.86
6.33
5.6
2.9
umol/l
8.6
7.2
0.19
30
124
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
0
+∞
6.29
1.8
0.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
63
3.69
6.25
1.7
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
98
650
2.34
6.18
13.2
5.3
umol/l
13.2
11.3
0.58
93
612
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
23
5.56
6.11
4.7
2.5
e9/l
3.7
3.9
0.14
12
23
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
23
5.56
6.11
5.7
2.6
%
55.6
58.5
0.21
12
23
(3037756) Immunofixation for Serum or Plasma
12
23
5.56
6.11
1.4
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
28
103
3.09
6.08
5.9
4.8
mmol/l
1.8
1.8
0.00
22
72
(3021440) Promyelocytes/100 leukocytes in Blood
26
93
3.15
5.91
12.5
3.7
%
0.1
0.2
0.50
16
26
(3042936) Bacteria identified in Isolate by Culture
38
170
2.63
5.75
2.7
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
25
89
3.15
5.72
11.6
3.8
%
0.0
0.4
0.56
14
22
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
17
6.21
5.70
14.7
2.2
pg
33.9
32.0
—
10
17
(3017181) Myelocytes/100 leukocytes in Blood
27
102
2.99
5.59
12.4
3.6
%
0.5
0.9
0.80
16
32
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
32
136
2.70
5.34
2.2
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
82
3.11
5.24
1.8
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
24
88
3.04
5.22
12.9
3.6
%
0.2
0.5
0.58
13
18
(3002256) Pathology report gross observation
33
147
2.57
5.00
1.5
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
134
2.63
4.99
2.3
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
44
227
2.30
4.84
5.4
3.4
ng/l
76.3
207.7
1.04
37
176
(3010503) CD19 cells [#/volume] in Blood
8
7
11.95
4.84
2.8
1.4
e9/l
0.1
0.1
—
8
7
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
38
3.95
4.76
3.4
2.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
82
545
2.05
4.68
23.5
9.0
e9/l
0.0
0.0
0.00
66
442
(36304419) Bacteria [Presence] in Urine
58
344
2.08
4.47
4.3
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
62
377
2.06
4.47
3.7
2.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
47
257
2.18
4.47
1.9
1.3
g/l
2.0
2.3
0.52
30
147
(3032080) INR in Blood by Coagulation assay
75
492
2.00
4.36
10.6
9.4
inr
1.2
1.3
0.74
26
151
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
6
12.12
4.31
1.1
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
45
245
2.17
4.31
3.0
2.9
mosm/kgh2o
508.6
544.6
0.57
35
207
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
87
2.78
4.18
4.5
7.5
mmol/l
2.8
1.5
0.78
16
66
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
10
8.35
4.11
1.7
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
7
10.39
4.05
1.0
2.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
7
10.39
4.05
1.0
2.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
24
4.38
3.95
1.5
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
24
4.38
3.95
1.5
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
59
366
1.98
3.94
4.7
2.9
u/l
37.8
32.7
0.44
52
346
(3000850) Epithelial cells [#/volume] in Urine
47
270
2.05
3.88
3.3
2.5
e6/l
2.6
5.0
2.42
40
238
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
22
91
2.65
3.84
2.7
3.3
ng/l
272.5
176.3
0.33
22
79
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
45
257
2.05
3.76
2.7
1.7
mg/l
0.8
1.4
1.48
34
189
(3027315) Oxygen [Partial pressure] in Blood
10
25
4.20
3.76
6.6
2.3
kpa
9.4
8.6
—
10
25
(3013290) Carbon dioxide [Partial pressure] in Blood
10
25
4.20
3.76
6.6
2.3
kpa
4.8
5.1
—
10
25
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
8
12
6.95
3.72
1.5
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
12
6.95
3.72
1.1
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
111
865
1.95
3.60
4.5
3.7
pmol/l
15.0
14.9
0.12
105
757
(3014576) Chloride [Moles/volume] in Serum or Plasma
29
142
2.28
3.55
11.4
6.5
mmol/l
104.6
104.2
0.12
29
137
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
13
6.42
3.54
1.0
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
68
456
1.86
3.52
4.7
3.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
77
2.67
3.45
1.8
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
56
355
1.89
3.43
4.1
3.2
mmol/l
6.8
7.6
0.74
49
291
(3037522) Nuclear Ab [Titer] in Serum
28
137
2.27
3.43
1.4
1.4
titre
173.3
685.9
—
6
34
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
27
3.89
3.41
2.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
48
3.10
3.39
2.5
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
53
334
1.88
3.29
4.3
3.2
mg/l
89.9
258.2
0.40
35
210
(3000012) Reticulocyte production index
6
7
8.85
3.29
3.0
2.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
7
8.85
3.29
1.8
2.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
11
6.60
3.22
1.4
4.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
44
3.13
3.22
2.4
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
13
45
3.06
3.10
1.2
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
59
392
1.81
3.06
4.7
3.3
e6/l
18.9
58.6
1.85
49
306
(3018095) Leukocytes [#/volume] in Urine
66
454
1.78
3.05
5.4
3.9
e6/l
89.3
69.8
0.15
53
324
(3010421) pH of Blood
10
30
3.49
2.96
7.1
2.2
ph
7.4
7.4
—
10
25
(4062490)
6
9
6.87
2.89
1.2
1.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
6
9
6.87
2.89
2.2
1.9
mg/l
9.8
3.6
—
6
9
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
57
381
1.78
2.87
4.6
3.2
ng/l
2199.6
1304.8
1.09
50
316
(3037467) Urinalysis macro (dipstick) panel - Urine
107
855
1.78
2.86
6.3
4.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
68
479
1.74
2.85
2.5
2.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
6
8.55
2.77
2.2
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
65
457
1.72
2.72
6.5
3.8
ng/l
73.5
34.9
0.80
51
331
(3024928) Oxygen saturation in Venous blood
8
19
4.38
2.71
1.9
2.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
32
3.27
2.69
1.2
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
53
355
1.74
2.62
4.6
3.2
e6/l
0.1
0.3
2.27
44
267
(3035637) Corticotropin [Mass/volume] in Plasma
6
11
5.62
2.56
1.3
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
110
2.16
2.56
1.8
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
34
201
1.88
2.51
3.9
3.3
e6/l
0.8
2.1
0.99
20
112
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
12
5.15
2.42
2.3
1.8
—
—
—
0
0
(4035726)
22
113
2.10
2.40
1.8
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
43
278
1.75
2.38
1.4
1.2
u/ml
2.8
1.1
0.37
12
68
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
35
2.98
2.35
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
175
1.88
2.31
1.3
1.3
iu/ml
29.2
24.7
—
10
56
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
13
4.75
2.29
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
51
350
1.68
2.27
5.7
4.1
mg/mmol
15.7
60.9
0.41
37
215
(3022313) Gas panel - Capillary blood
15
67
2.37
2.25
4.9
6.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
36
2.90
2.24
3.7
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
98
794
1.62
2.21
5.2
3.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
24
3.45
2.21
2.3
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
19
3.80
2.17
2.4
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
19
3.80
2.17
3.1
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
14
4.41
2.17
2.3
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
125
1080
1.75
2.17
5.6
4.5
mu/l
2.1
2.0
0.31
118
960
(3000764) Benzodiazepines [Presence] in Urine
11
43
2.67
2.14
1.5
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
94
758
1.59
2.13
5.2
2.8
u/l
82.5
49.0
1.15
88
700
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
31
3.02
2.11
3.1
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
31
3.02
2.11
3.1
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
20
3.61
2.08
2.3
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
14
63
2.34
2.08
4.7
6.9
mmol/l
25.0
24.5
0.19
14
63
(3027944) Amphetamines [Presence] in Urine
11
44
2.61
2.06
1.5
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
44
2.61
2.06
1.5
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
44
2.61
2.06
1.5
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
15
4.11
2.06
2.7
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
15
70
2.26
2.06
4.9
3.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
46
317
1.64
1.99
1.6
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
21
3.44
1.99
1.9
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
135
1203
1.84
1.97
37.1
13.5
mg/l
23.1
23.7
0.08
122
945
(3015377) Calcium [Moles/volume] in Serum or Plasma
56
406
1.59
1.97
4.6
3.1
mmol/l
2.4
2.4
0.12
48
344
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
58
2.35
1.97
2.5
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
27
3.06
1.96
1.9
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
11
4.65
1.95
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
34
217
1.72
1.95
3.7
2.8
e6/l
0.6
1.0
0.57
20
126
(3009542) Hematocrit [Volume Fraction] of Blood
123
1071
1.67
1.92
33.7
14.5
%
36.8
39.8
4.05
89
746
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
123
1.92
1.92
6.5
2.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
37
244
1.67
1.88
13.1
5.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
40
2.60
1.87
1.5
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
17
3.62
1.85
12.7
2.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
17
3.62
1.85
9.0
3.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
12
4.26
1.83
1.4
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
35
2.66
1.83
1.3
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
28
172
1.76
1.83
1.3
1.3
u/ml
50.0
14.1
—
6
75
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
18
3.42
1.76
1.0
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
24
3.00
1.74
1.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
13
3.93
1.73
3.0
1.8
%
60.9
57.7
—
5
13
(3021788) Differential panel - Synovial fluid
5
13
3.93
1.73
2.0
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
13
3.93
1.73
1.6
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
13
3.93
1.73
2.4
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
25
2.88
1.67
3.7
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
14
3.65
1.63
1.4
2.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
26
2.77
1.60
5.3
3.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
137
1246
1.75
1.59
31.8
12.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
27
2.66
1.53
1.4
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
88
733
1.45
1.50
3.1
3.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
9
38
2.45
1.48
1.9
1.1
g/l
0.3
0.2
—
9
38
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
16
3.19
1.45
3.0
3.3
nmol/l
6.7
3.1
—
5
16
(44806118)
5
16
3.19
1.45
2.8
2.0
—
—
—
0
0
(44790049)
5
16
3.19
1.45
2.8
2.0
—
—
—
0
0
(44790047)
5
16
3.19
1.45
2.8
2.0
—
—
—
0
0
(44790048)
5
16
3.19
1.45
2.8
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
22
2.79
1.45
1.3
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
9
40
2.32
1.42
1.9
1.2
g/l
1.3
1.1
—
9
40
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
19
113
1.77
1.39
2.2
2.2
ug/l
11.4
5.0
0.57
14
92
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
17
3.00
1.37
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
20
123
1.72
1.32
1.7
1.5
%
1.5
1.4
0.46
15
108
(3021901) Oxygen saturation in Capillary blood
6
24
2.56
1.31
3.8
5.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
44
2.11
1.29
1.1
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
44
2.11
1.29
1.1
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
44
2.11
1.29
1.1
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
19
2.68
1.22
1.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
64
1.95
1.21
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
31
218
1.53
1.21
4.7
2.9
mmol/l
2.5
2.4
1.53
23
188
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
26
2.36
1.20
1.2
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
33
0.00
1.17
0.0
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
35
0.00
1.16
0.0
4.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
18
112
1.69
1.15
4.8
3.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
30
2.39
1.14
1.6
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
30
2.39
1.14
1.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
40
2.05
1.14
1.8
2.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
16
99
1.69
1.04
14.9
2.8
mmol/l
1.2
1.2
0.45
16
86
(3021601) Nitrite [Presence] in Urine by Test strip
72
606
1.35
1.04
6.5
5.0
estimate
0.0
0.0
0.00
21
120
(3005033) Fetal Nuchal fold Thickness US
0
31
0.00
0.97
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
31
0.00
0.97
0.0
1.5
—
—
—
0
0
(3015736) pH of Urine
58
477
1.34
0.96
3.7
3.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
28
2.19
0.92
1.8
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
42
1.95
0.90
1.9
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
72
617
1.31
0.88
4.6
3.7
estimate
0.0
0.0
0.00
21
112
(36660697) Celiac disease serology panel - Serum
14
88
1.65
0.87
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
71
611
1.29
0.83
4.6
3.7
estimate
0.0
0.0
0.00
21
119
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
32
1.91
0.82
2.5
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
18
124
1.51
0.79
1.4
1.2
—
—
—
0
0
(3013512) EKG study
44
357
1.32
0.79
5.1
3.9
—
—
—
0
0
(3000492) Spirometry study
14
91
1.59
0.78
1.6
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
34
1.79
0.77
1.7
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
24
2.12
0.75
1.0
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
42
341
1.32
0.75
4.5
3.8
estimate
0.0
0.0
0.00
19
118
(3020891) Body temperature
7
38
1.88
0.74
7.7
3.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
281
1.32
0.67
3.6
3.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
120
1121
1.29
0.66
33.6
12.4
ml/min/173m2
73.7
79.9
1.47
105
898
(3000494) Fungus identified in Specimen by Culture
20
149
1.39
0.61
2.9
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
123
1158
1.28
0.60
5.4
4.8
mmol/l
2.5
2.7
1.18
114
1049
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
35
1.74
0.58
2.3
2.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
73
1.54
0.58
1.1
1.6
—
—
—
0
0
(3019225) pH of Specimen
16
118
1.40
0.52
8.4
4.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
41
348
1.24
0.52
4.8
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
12
85
1.45
0.48
4.5
3.7
ml/min/173m2
60.7
63.4
—
6
29
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
114
1078
1.21
0.45
4.4
3.9
mmol/l
1.4
1.2
1.57
104
979
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
222
1.26
0.45
3.2
2.9
ug/l
1.2
0.8
0.31
18
153
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
18
0.00
0.40
0.0
2.3
—
4.1
—
0
18
(3035285) Chloride [Moles/volume] in Venous blood
0
18
0.00
0.40
0.0
2.3
—
106.2
—
0
18
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
18
0.00
0.40
0.0
2.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
18
0.00
0.40
0.0
2.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
107
1.34
0.38
1.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
36
1.40
0.38
1.4
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
71
1.28
0.37
1.1
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
117
1120
1.17
0.34
4.7
4.3
mmol/l
1.4
1.5
1.67
109
1015
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
154
0.76
0.34
8.5
7.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
118
1131
1.17
0.33
4.8
4.3
mmol/l
4.3
4.5
1.32
109
1032
(3027273) Bicarbonate [Moles/volume] in Venous blood
7
54
1.31
0.31
5.4
4.0
mmol/l
25.8
24.9
—
7
54
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
57
1.24
0.29
1.4
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
117
1126
1.15
0.29
5.9
4.6
mmol/l
6.0
5.9
0.08
108
1012
(3050129) First trimester maternal screen panel - Serum or Plasma
5
37
1.36
0.24
1.6
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
93
0.74
0.23
1.4
1.3
—
—
—
0
0
(1002224) Polysomnography panel
5
42
1.20
0.21
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
15
175
0.84
0.20
1.6
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
51
1.18
0.19
4.0
2.4
%
1.7
1.1
—
6
51
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
226
0.87
0.18
1.8
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
58
1.22
0.18
1.9
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
51
478
1.10
0.18
4.8
3.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
101
1.20
0.17
2.8
3.4
—
—
—
0
0
(4010399)
7
86
0.81
0.15
1.0
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
53
1.14
0.09
5.2
5.6
%
34.1
43.7
—
6
53
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
133
0.89
0.08
2.4
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
112
0.89
0.07
2.3
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
77
1.04
0.07
2.0
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
89
1.13
0.07
4.7
2.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
32
309
1.04
0.04
3.6
4.5
%
24.7
22.2
0.25
15
163
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
40
389
1.04
0.03
5.6
5.2
ug/l
2.2
2.6
0.29
30
342
(1761868) Lipid panel - Serum or Plasma
36
367
0.98
0.01
2.5
2.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
119
1.01
0.00
2.4
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
81
0.99
0.00
1.6
1.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
8
80
1.00
0.00
2.3
2.4
—
21.9
—
0
5
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.2
—
1335.2
—
0
5
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7
74
0.94
0.00
1.1
1.2
—
39.1
—
0
6
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
53
0.94
0.00
1.6
1.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.4
—
875.0
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
74
0.94
0.00
1.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
60
1.00
0.00
1.8
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.9
—
27.0
—
0
8
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
8.9
—
0
5
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_ACQPUREREDCLLAPLASIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_ACQPUREREDCLLAPLASIA | 2.385 [1.8, 3.16] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.612 |
During the follow-up period (1.1.1998 — 31.12.2019), 214 out of 643 females with D3_ACQPUREREDCLLAPLASIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_ACQPUREREDCLLAPLASIA | 3.507 [2.19, 5.62] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 220 out of 570 males with D3_ACQPUREREDCLLAPLASIA died.
Mortality risk
Mortality risk for people of age
years, who have D3_ACQPUREREDCLLAPLASIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.271% | 0.578% |
| 5 | 1.616% | 3.729% |
| 10 | 4.04% | 9.649% |
| 15 | 7.368% | 16.673% |
| 20 | 12.727% | 26.796% |
Relationships between endpoints
↥Index endpoint: D3_ACQPUREREDCLLAPLASIA – Acquired pure red cell aplasia [erythroblastopenia]
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data